Back to Directory

Olga Varechtchouk

Email

olga.varechtchouk@nih.gov

Phone

240-712-1302

Institution

Prevention Science Program, DAIDS, NIAID, NIH, DHHS

Title

Medical Officer

Address

DAIDS, NIAID, NIH, DHHS
5601 Fishers Lane
Rockville, MD 20852
USA

Request an Update

Affiliated Studies

IMPAACT 2037: Open-Label, Phase I Study of the Safety and Pharmacokinetics of PGT121.414.LS alone and in combination with VRC07-523LS in Infants Exposed to HIV-1

DAIDS Number

38962

Research Area

Therapeutics

Study Status

Enrolling

IMPAACT 2053: Long-Acting Injectable Cabotegravir as Postnatal Prophylaxis During Breastfeeding: Safety, Tolerability, and Model Development for Implementation

DAIDS Number

39282

Research Area

Therapeutics

Study Status

In Development

IMPAACT 2052: Safety and pharmacokinetics of an AAV-Vectored broadly neutralizing antibody in infants living with HIV

DAIDS Number

39268

Research Area

Cure and Immunotherapy

Study Status

In Development

IMPAACT 2024 : Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV.

DAIDS Number

38747

Research Area

Tuberculosis

Study Status

Enrolling

IMPAACT 2048/HVTN 145: Phase I Study of the Safety and Pharmacokinetics of VRC07-523LS, ePGT121v1-LS, and PDGM1400LS Alone and in Combination in Breastfeeding Infants

DAIDS Number

TBD

Research Area

Therapeutics

Study Status

In Development

Show All